MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 124832-26-4
Formula C13H20N6O4MW 324.34Research-use catalog entryCOA/SDS by request

Valacyclovir

CAS Number: 124832-26-4

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Supply options

Availability by request

Availability
Available by request
Documents
COA/SDS available on request
Shipping
Shipping reviewed before dispatch

Public pricing is not shown for this CAS. Submit an RFQ to confirm availability, documentation, and shipping review.

Loading RDKit molecule structure...
InChIKey: HDOVUKNUBWVHOX-QMMMGPOBSA-NC13H20N6O4 | MW 324.34

Chemical Absolute Identifiers

CAS Number

124832-26-4

PubChem CID

135398742

Molecular Formula

C13H20N6O4

Molecular Weight

324.34 g/mol

Exact Mass

324.154603

InChIKey

HDOVUKNUBWVHOX-QMMMGPOBSA-N

IUPAC Name

2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate

SMILES String

CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N

Physical Properties

pKa

1.9

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Valacyclovir (CAS 124832-26-4) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C13H20N6O4 and molecular weight 324. 34 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Solute carrier family 15 member 1 (Homo sapiens) — 8 assays; Alpha-1A adrenergic receptor (Homo sapiens) — 4 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2A (Homo sapiens) — 3 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Solute carrier family 15 member 1

Homo sapiens · SINGLE PROTEIN · 8 qualifying assays · 4 documents

Experimental evidence source: ChEMBL

Alpha-1A adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 1A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2B

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Valacyclovir

Names & Synonyms

ValaciclovirValACVZelitrexVal-ACVL-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine
Show all synonyms
L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl esterL-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoateValaciclovirumL-valylacyclovirL Valylacyclovir2-((2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy)ethyl (2S)-2-amino-3-methylbutanoateL-valyl Ester Acycloviracyclovir, L-valyl esterAcyclovir, L valyl Ester2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinateValtrexValcyclovirValaciclovir (INN)Valtrex (TN)
External Identifiers
EC NUMBER: 603-015-6EC NUMBER: 658-047-3DSSTOX SUBSTANCE ID: DTXSID1023732CHEMBL ID: CHEMBL1349CHEBI ID: CHEBI:35854UNII: MZ1IW7Q79DDRUGBANK ID: DB00577HMDB ID: HMDB0014716KEGG ID: D08664METABOLOMICS WORKBENCH ID: 42909NCI THESAURUS CODE: C28235PHARMGKB ID: PA451839WIKIDATA ID: Q418594
Literature & Patent References
DOI 10.1016/j.isci.2024.108907Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelPMID 38318365Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelDOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.PMID 37468498A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.1021/acs.jmedchem.2c00668Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.PMID 36202389Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.DOI 10.1021/acs.jmedchem.1c00790Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.DOI 10.6019/CHEMBL4651402Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochlorideCAS 124832-27-5
2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-oneCAS 59277-89-3
2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-oneCAS 39809-25-1

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 124832-27-52-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochlorideCAS 59277-89-32-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-oneCAS 100643-71-8DesloratadineCAS 132539-06-1OlanzapineCAS 169590-42-5CelecoxibCAS 30516-87-1ZidovudineCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylate

RFQ questions for CAS 124832-26-4

What are the key identifiers for Valacyclovir (CAS 124832-26-4)?

Valacyclovir is identified by CAS 124832-26-4, with molecular formula C13H20N6O4, molecular weight 324.34, InChIKey HDOVUKNUBWVHOX-QMMMGPOBSA-N.

Does CAS 124832-26-4 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Solute carrier family 15 member 1, Alpha-1A adrenergic receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 124832-26-4?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Valacyclovir?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 124832-26-4 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.